SG Americas Securities, LLC - CONCERT PHARMACEUTICALS INC ownership

CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of CONCERT PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$119
-99.9%
20,361
+19.7%
0.00%0.0%
Q3 2022$114,000
-26.9%
17,009
+8.4%
0.00%0.0%
Q2 2020$156,000
+2.0%
15,686
+51.3%
0.00%0.0%
Q3 2017$153,00010,3670.00%
Other shareholders
CONCERT PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
BVF INC/IL 2,253,000$7,097,0000.26%
INGALLS & SNYDER LLC 1,358,573$4,280,0000.19%
RA Capital Management 3,033,603$9,556,0000.17%
Kensington Investment Counsel, LLC 85,483$269,0000.16%
Perceptive Advisors 4,301,282$13,548,0000.10%
NewEdge Wealth, LLC 381,326$1,201,0000.05%
Black Diamond Financial, LLC 46,000$145,0000.05%
Birchview Capital, LP 20,000$63,0000.04%
XTX Topco Ltd 14,305$45,0000.02%
Alyeska Investment Group, L.P. 548,090$1,726,0000.02%
View complete list of CONCERT PHARMACEUTICALS INC shareholders